739 Cardiovascular (CV) assessments in short- and long-term Phase 3 mirabegron trials in patients with overactive bladder (OAB)
| Autor: | Herschorn, S., Kowey, P., Nitti, V., Milsom, I., Auerbach, S.M., Blauwet, M.B., Dorrepaal, C., Weber, M., Borer, J.S., Fitzsimmons, W., Martin, N. |
|---|---|
| Zdroj: | In European Urology Supplements March 2013 12(1):e739-e740 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect